News in the Life Sciences Industry

GYEONGGI, South Korea, Feb. 14, 2019 /PRNewswire/ -- SK Biopharmaceuticals and Arvelle Therapeutics GmbH today announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe. Cenobamate is a novel, small molecule investigational... Read more ››

PINE BROOK, New Jersey, February 14, 2019 /PRNewswire/ --

OSAKA, Japan, Jan. 30, 2019 /PRNewswire/ -- As part of its efforts to raise public awareness of glaucoma, Santen Pharmaceutical Co., Ltd. (hereinafter "Santen"), based in Osaka, will sponsor glaucoma awareness-raising activities to be conducted around the world during the World Glaucoma Week,... Read more ››

SINGAPORE, Jan. 22, 2019 /PRNewswire/ -- Mundipharma will be introducing BETADINE(TM) Cold Defence, a new early treatment hailed as a "world-first" ([i]), in the Middle East and Africa to help families stay healthy and fight the common cold.

SUWON, South Korea, Jan. 18, 2019 /PRNewswire/ -- OLX10020, a cell-penetrating asymmetric siRNA ("cp-asiRNA") against a novel target (Undisclosed) for treatment of Geographic Atrophy ("GA"), proved effective in both Dry and Wet AMD animal models and to be submitted an IND application to the... Read more ››